EIF4EBP1 and non-small cell lung carcinoma: Our data showed that the survival time of patients with high p-4EBP1 is shorter than patients with low expressed p-4EBP1, and p-4EBP1 could be used as an independent prognostic indicator of NSCLC, regardless of clinical stage, LNM, and pathological grade.